Decoding psoriasis: pathological mechanisms, evolving treatments, clinical investigations, and future perspectives
- 24 March 2026
- journal article
- review article
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 45 (3) , 1-15
Abstract
1. Psoriasis represents a persistent, immune-mediated dermatological disorder characterized by inflammation and scaling plaques that result from abnormal keratinocyte proliferation. The global prev...Keywords
This publication has 76 references indexed in Scilit:
- Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 YearsJAMA Dermatology, 2025
- Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in PsoriasisJAMA Dermatology, 2024
- Biologics‐Loaded Photothermally Dissolvable Hyaluronic Acid Microneedle Patch for Psoriasis TreatmentAdvanced Functional Materials, 2022
- Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus RecommendationsDermatology and Therapy, 2021
- Novel nanocrystal-based formulations of apremilast for improved topical deliveryDrug Delivery and Translational Research, 2020
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis PathogenesisClinical Reviews in Allergy & Immunology, 2018
- Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque PsoriasisJAMA Dermatology, 2016
- Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic ReviewDermatology and Therapy, 2015
- Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel DiseaseArthritis & Rheumatology, 2014